Clinical data indicate that the measurement of serum ghrelin concentration may be useful in prognosis of postoperative courses in patients undergoing esophagectomy with gastric tube reconstruction due to esophageal cancer, as well as in patients after pancreatoduodenectomy. The gene discussed is GHRL; the disease is esophageal cancer.